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Ligand-mediated G-quadruplex Induction in a Double-stranded 
DNA Context by Cyclic Imidazole/Lysine Polyamide 
Sefan Asamitsu,[a] Yue Li,[a] Toshikazu Bando,*[a] and Hiroshi Sugiyama*[a,b]  
Abstract: G-quadruplex (G4) DNA is often observed as a DNA 
secondary structure in guanine-rich sequences and is thought to be 
relevant to pharmacological and biological events. Therefore, G4 
ligands have attracted great attention regarding potential anticancer 
therapies or molecular probe applications. In the present study, we 
designed cyclic imidazole/lysine polyamide (cIKP) as a new class of 
G4 ligand, which was readily synthesized without time-consuming 
column chromatography. cIKP enables the selective recognition of 
particular G4 structures with low nanomolar affinity. Moreover, cIKP 
exhibited the ability to induce G4 formation on the promoter of G4-
containing DNAs in the context of stable double-stranded DNA 
(dsDNA) under molecular crowding conditions. This cIKP may be 
applicable as a molecular probe for the detection of potential G4-
forming sequences in dsDNA.  
Introduction 
G-quadruplex (G4) DNA is the higher-order structure of four-
stranded nucleic acids including several G-quartets comprising 
four planar guanines that stabilize each other via Hoogsteen 
hydrogen bonding. G4 structures can be formed in G-rich 
sequences, and monovalent metal cations (K+ or Na+) reinforce 
the stability of such structures.[1] It has been shown that G4-
forming sequences are widely present in human genomes, 
notably in the promoter and 5-UTR regions of genes that are 
involved in cellular proliferation or are relevant to several diseases, 
as well as in telomere sequences.[2] Hence, G4 structures have 
attracted great attention regarding biological events, including 
gene alteration,[3a,b] epigenetic regulation,[3c] genome stability,[3d] 
and targets for these therapies.[3e–g] To date, several synthetic 
molecules have been reported as G4 ligands, such as flat 
aromatic, macrocyclic, and crescent-shaped compounds.[4] In 
particular, the fact that a naturally occurring macrocycle, 
telomestatin, exhibits telomerase-inhibition activity by binding to 
telomeric G4 structures has accelerated attempts to study 
synthetic macrocycles for the direct targeting of these structures, 
aiming to develop potential anticancer therapies or molecular 
probe applications.[3d,5] For example, furan-based cyclic 
oligopeptides were shown to be highly selective for G4 structures, 
and some cyclic oligopeptides (24-membered rings) suppressed 
the mRNA expression of the c-Myc oncogene, the promoter of 
which contains G4-forming sequences.[6] A cationic telomestatin 
derivative shows strong binding affinity for telomeric G4 over other 
G4 structures.[7] In addition to these compounds, several 
macrocyclic compounds have been reported as G4 ligands, and, 
in some cases, G4 topology selectivity was successfully 
achieved.[3b,8] Therefore, such macrocyclic structures are 
attractive scaffolds to achieve both binding affinity and selectivity 
for particular G4 structures. 
For years, we have studied a synthetic DNA minor groove binder 
named pyrrole–imidazole polyamide (PIP). PIP was developed by 
Prof. Dervan and colleagues as a programmable DNA-binding 
molecule and distinctly recognized A/T base parings and G/C 
base parings with modest affinity and specificity.[9] In the course 
of such PIP studies, we have reported that consecutive imidazole 
rings held together via amide bonds adopt a highly planar 
conformation, as estimated by density functional theory.[10] In the 
present study, we designed cyclic Imidazole/Lysine Polyamide, 
cIKP (1) as a new class of G4 ligand, which was readily 
synthesized and which enabled selective recognition of the 
particular G4s with higher binding affinity compared to TMPyP4, 
a well-studied G4-interactive compound (Figure 1). Furthermore, 
cIKP exhibited the ability to induce G4 formation on the promoter 
G4 DNAs in the context of stable dsDNA under molecularly 
crowded conditions. 
Results and Discussion 
Molecular design and synthesis 
 
Based on the above mentioned report, the imidazole moiety was 
selected as a key component for the molecular planarity of the 
structure, although other heteroaromatic rings were widely used 
to construct the planar backbones of most of the other 
macrocyclic G4 ligands.[4a,11] The lysine residue was adopted as 
another core mainly because its positively charged side chains 
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Figure 1. Chemical structures of cIKP (1) (a) and TMPyP4 (b).  
cIKP (1) TMPyP4 
(a) (b) 
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can electrostatically interact with the negatively charged 
phosphate backbone of the G4s.[12] Although the incorporation of 
the two lysine moieties seems likely to sacrifice the high planarity 
of the molecule, the relatively flexible compound could mold into 
the surface of the G-quartet.[12] cIKP (1) was synthesized as 
shown in Scheme 1. We successfully synthesized the target 
compound using a total of nine steps without any time-consuming 
chromatographic purification, with the exception of that of the final 
product. Moreover, although, generally, 2 or 3 days are necessary 
to finish the ring-closing step upon the construction of the 
macrocyclic backbone in low yield,[6,7,8b] the dimerization of the 
linear imidazole/lysine polyamide gave a better yield and reduced 
the reaction time. This may be attributed to internal H-bond 
formation between the N of imidazole and the H of the adjacent 
amide.[10] Three commonly used condensation agents, PyBOP, 
HCTU, and DPPA, were applicable to this dimerization reaction, 





To evaluate the binding properties of 1 for G4s and double-
stranded DNAs (dsDNA) quantitatively, we performed an SPR-
binding assay (Figure 2).[13] We selected five DNAs harboring G4-
forming sequences located in a human telomere, and the 
promoter regions of the c-Myc, c-kit-1, c-kit-2, and BCL2 genes, 
which were studied well via quantitative analysis using SPR-
binding assays (Table S1).[6,14] The sensorgrams obtained for c-
Myc or telomeric/c-kit-1/c-kit-2/BCL2 G4s were better fitted by a 
single-site or a two-site model, respectively, suggesting a 1:1 or 
2:1 stoichiometry for the binding of 1 to c-Myc or telomeric/c-kit-
1/c-kit-2/BCL2 G4s within optimized concentration ranges. These 
two fitting models include equations that reflect mass transfer 
limitation effect. The association rate (ka), dissociation rate (kd), 
and dissociation constant (KD) for the interaction of 1 with the G4 
DNAs are shown in Table 1. For telomeric/c-kit-1/c-kit-2/BCL2 
G4s, 1 exhibited a preference for one site over the other. The 
kinetic parameters and dissociation constants for the weaker 
Scheme 1. Synthetic route of cIKP (1) in solution-phase. Compound 2 was prepared from NO2-I-COCCl3. Reagents and conditions; (i) H2, 10 wt% Pd/C, AcOEt, 
MeOH, rt. (ii) BocNH-Lys(Cbz)-OH, HCTU, DIEA, DMF, rt, 64% over two steps. (iii) NaOH, MeOH, H2O, 45 oC. (iv) TFA, DCM, rt. (v) FDPP, DIEA, DMF, rt, 52% 



























































































































































Figure 2. SPR-binding assays to evaluate the binding properties of cIKP (1). Each SPR sensorgram is fitted with an appropriate fitting model (black line). (a) SPR 
sensorgrams for interactions with telomere G4. (b) SPR sensorgrams for interactions with c-Myc G4. (c) SPR sensorgrams for interactions with c-kit-1 G4. (d) SPR 
sensorgrams for interactions with c-kit-2 G4. (e) SPR sensorgrams for interactions with BCL2 G4. 
(a) (b) (c) 
(d) (e) 
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binding sites were described in Table S2. Compound 1 showed 
higher affinity for c-Myc (6.2 nM), c-kit-1 (7.4 nM), c-kit-2 (3.8 nM), 
and BCL2 (17 nM) G4s, whereas it had modest affinity for the 
telomeric G4 (90 nM). This indicates that 1 has a 24-fold 
selectivity toward particular G4 structures (c-kit-2 vs telomeric 
G4s). Furthermore, a low response of 1 for duplex DNA (both GC-
rich and AT-rich sequences) was observed even at higher 
concentrations, indicating a significantly high selectivity toward 
G4 structures (Figure S1). Compared with the KD values of 
TMPyP4 (Figure 1b), which were measured for some G4s using 
the SPR method,[8h] 1 exhibited approximately 2-fold 
and 5–10-fold higher binding affinities for telomeric G4s and c-
Myc/c-kit-1 G4s, respectively. Collectively, 1 showed high 
selectivity and low nanomolar affinity toward G4 compared with 
dsDNA and exhibited some modest selectivity toward particular 
G4s. 
 
CD spectra analysis 
 
Next, we performed a CD spectra analysis to investigate the 
binding behavior of 1 to G4 structures using c-Myc, c-kit-1, c-kit-
2, and BCL2 G4s (Table S1). CD titration using several 
concentrations of 1 revealed that 1 can recognize and bind to G4 
structures and does not cause conformational changes upon 
binding (Figure S2).  Moreover, the ability of 1 to form G4 
structures was evaluated in the absence of K+ (Figure S3).[15] 
Regarding c-Myc, c-kit-2, and BCL2 ssDNA, no significant 
differences were observed compared with the case of the 
presence of K+, suggesting that 1 forms the same G4 structures 
according to CD spectra (Figure S3a,c,d).[16] Conversely, 1 
exhibited a different behavior for c-kit-1 ssDNA, including the 
amplitude of the positive peak detected at 295 nm (Figure S3b). 
This suggests that 1 drives c-kit-1 ssDNA to form hybrid or 
antiparallel/parallel mixed G4s instead of the parallel structure.[16] 
Those results demonstrate that 1 has the ability to form G4 
structures from ssDNA. 
 
 
Induction of G4 formation in dsDNA context 
 
In living cells, genomic DNA is usually present as a double helix. 
We examined the binding properties of 1 for four G4s located in 
the promoter regions in the presence of their complementary 
strands. A previous pioneer work clearly reveled induction of G4 
formation by a small molecule using the core G4-forming 
sequence and its complementary strand by gel electrophoresis.[17] 
Table 1. Values of the association rates (ka) and dissociation rates (kd) 
obtained from curve fittings of the sensorgrams, and dissociation constants 
(KD). 
 cIKP (1) 
DNA ka [M-1s-1] kd [s-1] KD [nM] 
Telomere[a] 7.5×105 6.7×10-2 90 
c-Myc[b] 2.0×106 1.3×10-2 6.2 
c-kit-1[a] 2.2×106 1.6×10-2 7.4 
c-kit-2[a] 3.3×106 1.2×10-2 3.8 
BCL2[a] 2.4×106 4.1×10-2 17 
dsDNA[a] Few response Few response Few response 
[a] Determined by fitting with a modified heterogeneous ligand-binding 
model (two-site binding model). [b] Determined by fitting with a 1:1 binding 
model with mass transfer.  
(b) (c) (d) (e) 
(a) 
Figure 3. Induction of G4 formation by 1 in the presence of KCl, as assessed by native gel electrophoresis. (a) Schematic representation of G4 induction by the 
ligand. (b) c-Myc dsDNA, (c) c-kit-1 dsDNA, (d) c-kit-2 dsDNA, and (e) BCL2 dsDNA. Lane 1 is a positive control for G4 formation bands. Lane 4 shows dsDNA 
formation bands. Note that the two bands showing G4 formation for c-kit-1 and BCL2 are attributable to several potential G4 conformations on each sequence.[19] 
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To truly reflect and better understand G4 induction effect by 1 in 
the genomic DNA context, we employed DNAs that consisted of 
a single G4-forming sequence and two flanking duplex regions 
and their complementary DNAs, and conducted these 
experiments under molecularly crowded condition.[18] DNAs 
including a single G4-forming sequence and their complementary 
DNAs were annealed in 40% (w/v) PEG 200 solution. The DNA 
solution was incubated at 37 °C for 30 min in the presence or 
absence of 1 and was then subjected to native gel electrophoresis. 
As positive controls, poly-T sequences, with which the 
complementary sequences of G4-forming ones were replaced, 
were used to confirm the band showing the DNA containing a G4 
on the gel (Table S1). Such G4-containing DNAs migrated behind 
the same sequences remaining in the dsDNA.[18] The migration 
behavior of DNAs upon the addition of 1 are shown in Figure 3. 
Regarding the c-kit-1, c-kit-2, and BCL2 dsDNAs, G4s were 
almost not formed in the absence of 1, but migrated bands 
indicating G4 formation appeared after incubation with 1, with a 
mobility on the gel that corresponded to that of a positive control 
(Figure 3c–e). Note that two bands showing G4 for c-kit-1 and 
BCL2 can be attributed to several potential G4 conformations on 
each sequence.[19] Conversely, TMPyP4 did not exhibit the G4 
induction effect under the same conditions containing the PEG 
solution (Figure S4). Given that such G4 induction did not occur 
in the absence of PEG solution (Figure S5), 1 has the property of 
inducing G4 formation from the stable dsDNA under a molecular 
crowding condition. Regarding the c-Myc dsDNA, G4 had already 
been formed in the absence of 1 and, therefore, it is difficult to 
observe the induction effect by 1 in the dsDNA context (Figure 3b). 
To circumvent this problem, we performed the same experiment 
in the absence of KCl. Interestingly, even in the absence of KCl, 
such induction of G4 formation by 1 was observed (Figure S6). 
This result also demonstrates the induction ability of 1 to form G4 
structures in a stable dsDNA context. The dose-dependency 
observed in Figure S6 was not significant within the measured 
concentration ranges. We performed additional experiments 
using the lower concentration ranges of 1. The results are shown 
in Figure S7. Even in the lower concentration ranges, the dose-
dependency was not significant. We are unable to provide a 
definitive reason for the observations, but we propose two 
possible reasons for this. First, a ligand may remain on the G4 
structure that was induced by the ligand and, therefore, is not 
recruited for the next continuous G4 induction. Second, once G4 
structures are generated, the ligands may bind nonspecifically to 
the G4s through other weaker binding sites or additional ligands 
may aggregate G4-ligand complexes; these changes would be 
observed as greater SPR responses at higher concentrations. 
These factors might suppress the ability to induce G4 formation 
in the presence of increased concentrations of G4s. 
Conclusions 
We designed and synthesized cyclic imidazole/lysine polyamide, 
cIKP (1), as a new class of G4 ligand based on the high planarity 
of consecutive imidazole scaffolds, as hinted by structural studies 
of PIP. cIKP had high selectivity and affinity toward G4 structures 
over dsDNA, and modest selectivity for the particular G4 
structures (24-fold). Interestingly, cIKP displayed the ability to 
induce G4 formation, even in the presence of the complementary 
strand. In recent studies, researchers have reported several new 
motifs that formed stable intramolecular G4s in vitro, such as 
motifs with bulges, long loops, and (4n–1) guanines.[20] 
Considering the high affinity and induction ability of cIKP toward 
G4, we anticipate that it might be a promising molecular probe for 
the detection of such new motifs or relatively unstable G4 




1H NMR spectra were recorded on JEOL JNM ECA-600 spectrometer (600 
MHz for 1H and 150 MHz for 13C), with chemical shifts reported in parts per 
million relative to residual solvent and coupling constants in hertz. The 
following abbreviations were applied to spin multiplicity: s (singlet), d 
(doublet), dd (doublet of doublets), t (triplet), m (multiplet), br (broad). 
Regular column chromatography was performed using Silica Gel 60 (70–
230 mesh, Merck Chemicals). Analytical HPLC was performed on a Jasco 
Engineering PU-2080 plus series system using a 150 X 4.6 mm X-Terra 
MS C18 reversed-phase column in 0.1% TFA in water with acetonitrile as 
the eluent at a flow rate of 1.0 mL/min and a linear gradient elution of 0–
100% acetonitrile in 20 or 40 min with detection at 254 nm. Collected 
fractions were analyzed by ESI-TOF-MS (Bruker). Reversed-phase flash 
column chromatography was performed on CombiFlash Rf (Teledyne Isco, 
Inc.) using a 4.3 g reversed-phase flash column (C18 RediSep Rf) in 0.1% 
TFA in water with acetonitrile as the eluent at a flow rate of 18.0 mL/min 
and a linear gradient elution of 0–35% acetonitrile in 5–40 min with 
detection at 254 nm. 10wt% Pd/C and Pentafluorophenyl 
diphenylphosphinate (FDPP) were purchased from Aldrich. O-(1H-6-
chlorobenzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate 
(HCTU) were purchased from Peptide International. Diphenylphosphoryl 
azide (DPPA), O2N-I-COCl3, trifluoromethansulfonic acid (TfOH), and N,N-
dimethylformamide (DMF) were purchased from Wako, and (Benzotriazol-
1-yloxy)tripyrrolidinophosphonium hexafluorophosphate (PyBOP) was 
purchased from Novabiochem. BocHN-Lys(Cbz)-CO2H was purchased 
from Watanabe Chemical Industries, LTC. Diisopropylethylamine (DIEA) 
was purchased from Nacalai Tesque, Inc. Trifluoroacetic acid (TFA) was 
purchased from Kanto Chemical Co., Inc. Dichloromethane (DCM) was 
purchased from Sasaki chemical co., Ltd. The other reagents and solvents 
were purchased from standard suppliers and used without further 
purification. 
Synthesis of cIKP (1) 
Synthesis of compound 3 
To a solution of compound 2 (1.01 g, 3.28 mmol), which had been 
synthesized in 3 steps from NO2-I-COCCl3 in overall 83 % yield,[21] in 
AcOEt (40 mL) and MeOH (20 mL) was added 10 wt% Pd/C (90 mg). The 
solution was stirred at rt under H2 gas atmosphere (P = 0.21 MPa) for 2 h. 
After the filtration of Pd/C, the filtrate was concentrated on an evaporator 
to give the amine compound (803 mg, 2.88 mmol) as a light brown powder, 
which was used the next step without further purification. The amine 
compound (121 mg, 0.43 mmol), BocHN-Lys(Cbz)-CO2H (182 mg, 0.49 
mmol), HCTU (198 mg, 0.48 mmol) was dissolved in dry DMF (8 mL) and 
to the mixture was added DIEA (83 µL, 0.48 mmol). The solution was 
FULL PAPER    





stirred at rt for 2.5 h, then evaporated the solvent and washed with water 
to produce the oil crude, which are used in the next reaction step without 
further purification. For spectral data, it was purified by column 
chromatography (silica gel, Hexane:AcOEt 1:10) to give compound 3 as a 
white powder (203 mg, 73 % yield). 1H NMR (600 MHz, DMSO-d6) δ 10.32 
(s, 1H), 9.80 (s, 1H), 7.70 (s, 1H), 7.50 (s, 1H), 7.35-7.30 (m, 5H) 7.23 (t, 
J = 5.6 Hz, 1H), 6.97 (d, J = 7.6 Hz, 1H), 4.99 (s, 2H), 4.10 (dd, J = 13.7, 
8.9 Hz, 1H), 3.96 (s, 3H) 3.95 (s, 3H), 3.82 (s, 3H), 2.97 (t, J = 17 Hz, 2H), 
1.56 (m, 2H), 1.38 (s, 9H), 1.31 (m, 2H), 1.24 (m, 2H). 13C NMR (DMSO-
d6) δ 158.8, 156.1, 155.7, 155.4, 137.3, 136.2, 133.0, 131.3, 128.3, 127.7, 
115.4, 114.5, 99.5, 78.0, 65.1, 59.7, 54.2, 51.8, 35.6, 35.0, 31.5, 29.1, 28.2, 
22.8. ESI-MS m/z calcd for C30H40N8O8 [M+H] 641.3042, found 641.3112. 
Synthesis of compound 5  
To a solution of compound 3 (203 mg, 0.32 mmol) in MeOH (6 mL) and 
H2O (6 mL) was added a solid NaOH (460 mg), then the mixture was 
heated at 45 oC for 1 h. After the evaporation of MeOH, the resulting 
solution was acidized with 6N HCl aq to produce a white precipitation. It 
was collected by filtration and dried in vacuo to give the carboxylic acid 
(159 mg) as a white powder, which was used the next step without further 
purification. To a solution of the carboxylic acid (32.6 mg) in DCM (1.5 mL) 
was added TFA (1.5 mL). The solution was stirred at rt for 1 h, then 
evaporated the solvent and dried in vacuo to give the TFA salt of 
compound 4 as a light brown solid, which was used the next step without 
further purification. The salt of compound 4 and FDPP (79 mg, 0.21 mmol) 
was dissolved in dry DMF (8.7 mL) and to the mixture was added DIEA 
(54 µL, 0.31 mmol). The solution was stirred at rt for 4 h, then evaporated 
the solvent. The crude was dissolved in a minimum amount of DCM and 
recrystallized with Et2O to give compound 7 as a white powder (27.4 mg, 
52 % for 3 steps). Three ordinary condensation agents, PyBOP, HCTU, 
and DPPA, were also used for this dimerization reaction with comparable 
yield (40%, 36%, and 32%, respectively). 1H NMR (600 MHz, DMSO-d6) δ 
10.19 (s, 2H), 9.41 (s, 2H), 8.82 (d, J = 9.7 Hz , 2H), 7.52 (s, 2H), 7.46 (s, 
2H) 7.36-7.29 (m, 10H), 7.25 (t, J = 5.7 Hz, 2H), 4.99 (s, 4H), 4.59 (dd, J 
= 15.8, 9.6 Hz, 2H), 4.00 (s, 6H) 3.94 (s, 6H), 2.99 (t, J = 13.1 Hz, 4H), 
1.85 (m, 2H), 1.75 (m, 2H), 1.49-1.42 (m, 4H), 1.38-1.31 (m, 4H). 13C NMR 
(DMSO-d6) δ 168.8, 157.9, 156.1, 154.8, 137.3, 135.6, 134.7, 134.3, 133.2, 
128.3, 127.7, 114.9, 113.0, 65.1, 53.7, 34.9, 32.2, 28.9, 22.8. ESI-MS m/z 
calcd for C48H56N16O16 [M+H]+ 1017.4438, found 1017.4467. 
Synthesis of compound 1 
To a solution of compound 5 (11.6 mg, 11.4 µmol) in TFA (800 µL) was 
slowly added TfOH (80 µL). The solution was stirred at rt for 5 min, then 
poured into cold Et2O (5 mL) to produce a light brown precipitate, which 
was collected by a centrifuge. The pellet was purified by reverse-phase 
flash chromatography to give compound 1 as a white powder (10.9 mg, 
98 % yield). 1H NMR (600 MHz, DMSO-d6) δ 10.27 (s, 2H), 9.42 (s, 2H), 
8.86 (d, J = 9.6 Hz, 2H), 7.72 (br s, 4H), 7.53 (s, 2H) 7.46 (s, 2H), 4.61 (dd, 
J = 15.8, 9.6 Hz, 2H), 4.01 (s, 6H) 3.95 (s, 6H), 2.80 (t, J = 13.1 Hz, 4H), 
1.87 (m, 2H), 1.76 (m, 2H), 1.64-1.55 (m, 4H), 1.45-1.35 (m, 4H). 13C NMR 
(DMSO-d6) δ 169.3, 158.5, 155.3, 136.1, 135.2, 134.8, 133.7, 115.5, 113.6, 
54.0, 39.2, 35.4, 32.6, 27.1, 23.0. ESI-MS m/z calcd for C32H44N16O6 
[M+H]+ 749.3702, found 749.3704. 
SPR-binding experiments 
SPR experiments were performed on a Biacore X instrument (GE 
healthcare) acording to previous reports with some modifications. 5´ 
Biotinylated DNAs were purchased from JbioS (Table S1). The biotinylated 
DNAs were immobilized to streptavidin-functionalized SA sensor chips to 
obtain the desired immobilization level. SPR measurements were carried 
out using degassed and filtered HBS buffer (10 mM HPES pH 7.4, 150 mM 
NaCl, 3mM EDTA, and 0.005% Surfactant P20) with 0.1% DMSO and 100 
mM KCl at 25°C. A series of sample solutions with a wide range of 
concentrations were prepared in the buffer with 0.1% DMSO and 100 mM 
KCl, and injected at a flow rate of 20 µl/min. After each cycle, the samples 
remainig on the DNA was detatched with 50 mM NaOH/1M NaCl buffer 
until the baseline of the sensorgrams was recovered. Optimized 
concentration range was then selected for the subsequent quantitative 
anlalysis. The resulting sensorgrams were fitted with 1:1 (single site) or 
modified heterogenous ligand (two site) binding model with mass tranfer 
using BIAevaluation 4.1 program in order to obtain the values of kinetics 
parameters (ka and kd) and binding affinites (KD). These two fitting models 
include equations that reflect mass transfer limitation effect. The best fitted 
curves were shown in Figure 2. 
CD spactra measurements 
DNA samples for CD spectra were prepared in 10 mM Tris-HCl (pH 7.5) 
buffer. Annealing was performed by heating to 95 °C for 5 min and 
gradually cooling down to room temperature in the presence or absence 
of 1. For CD titration assays, to the solution of the annealed DNA (5 µM) 
in the buffer was added various concentrations of 1, the solution was 
incubated for 30 min. CD spectra were measured in 0.5-nm steps from 340 
to 220 nm using JASCO J-805LST Spectrometer in a 1-cm quartz cuvette, 
and shown in Figure S2 and S3. 
Native gel electrophoresis analysis 
DNA samples for gel electrophoresis were prepared in 10 mM Tris-HCl 
(pH 7.5) buffer containing 40% (w/v) PEG 200 with or without 50 mM KCl. 
The DNA samples was heated to 95 °C for 5 min and gradually cooled 
down to room temperature. 1 was added to the resulting DNA solution (200 
nM) and incubated for 30 min at 37 oC. Those samples were loaded on 
12% polyacrylamide gel containing 50mM KCl, and electrophoresed at 
4 °C, 100 V, in 1×TBE buffer containing 50 mM KCl for 90 min. The gel 
was stained with SYBR gold for 15 min and then imaged by FUJIFILM 
FLA-3000 (FUJIFILM). 
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G-quadruplex inducer: cyclic imidazole/lysine polyamide (cIKP) as a new class of 
G-quadruplex ligand was designed and synthesized. It exhibited the ability to induce 
G4 formation, even in the presence of the complementary strand. It may be 
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DNA Sequence (5’–3’) 
telomere  biotin-TTTAGGGTTAGGGTTAGGGTTAGGG 
c-Myc  biotin-TTTTGGGGAGGGTGGGGAGGGTGGGGAAGG 
c-kit 1 biotin-TTTAGGGAGGGCGCTGGGAGGAGGG 
c-kit 2  biotin-TTTCGGGCGGGCGCGAGGGAGGGG 
BCL2 biotin-TTTGGGCGCGGGAGGAAGGGGGCGGG 
GC-rich dsDNA biotin-GCCGCGCGCGCTTATTTTAAGCGCGCGCGGC 
AT-rich dsDNA biotin-GCCATATATATTTATTTTTAAATATATATGGC 
c-Myc ssDNA TGGGGAGGGTGGGGAGGGTGGGGAAGG  
c-kit 1 ssDNA AGGGAGGGCGCTGGGAGGAGGG 
c-kit 2 ssDNA CGGGCGGGCGCGAGGGAGGGT 
BCL2 ssDNA GGGCGCGGGAGGAATTGGGCGGG 
c-Myc dsDNA 
GCGGTTCTGAACTCGATAT GGGTGGGTAGGGTGGG ATTAGTGCTAGCTACGCG 
CGCGTAGCTAGCACTAAT CCCACCCTACCCACCC ATATCGAGTTCAGAACCGC 
CGCGTAGCTAGCACTAAT TTTTTTTTTTTTTTTT ATATCGAGTTCAGAACCGC 
c-kit 1 dsDNA 
GCGGTTCTGAACTCGATAT AGGGAGGGCGCTGGGAGGAGGG ATTAGTGCTAGCTACGCG 
CGCGTAGCTAGCACTAAT CCCTCCTCCCAGCGCCCTCCCT ATATCGAGTTCAGAACCGC 
CGCGTAGCTAGCACTAAT TTTTTTTTTTTTTTTTTTTTTT ATATCGAGTTCAGAACCGC 
c-kit 2 dsDNA 
GCGGTTCTGAACTCGATAT CGGGCGGGCGCGAGGGAGGGG ATTAGTGCTAGCTACGCG 
CGCGTAGCTAGCACTAAT CCCCTCCCTCGCGCCCGCCCG ATATCGAGTTCAGAACCGC 
CGCGTAGCTAGCACTAAT TTTTTTTTTTTTTTTTTTTTT ATATCGAGTTCAGAACCGC 
BCL2 dsDNA 
GCGGTTCTGAACTCGATAT GGGCGCGGGAGGAAGGGGGCGGG ATTAGTGCTAGCTACGCG 
CGCGTAGCTAGCACTAAT CCCGCCCCCTTCCTCCCGCGCCC ATATCGAGTTCAGAACCGC 
CGCGTAGCTAGCACTAAT TTTTTTTTTTTTTTTTTTTTTTT ATATCGAGTTCAGAACCGC 
 
  






















Table S2. Values of the association rates (ka) and dissociation rates (kd) obtained 
from curve fittings of the sensorgrams, and dissociation constants (KD) for the 
weaker binding sites. 
 cIKP (1) 
DNA ka [M-1s-1] kd [s-1] KD [nM] 
Telomere[a] 1.7×104 2.3×10-3 131 
c-kit-1[a] 3.7×104 9.8×10-3 262 
c-kit-2[a] 3.8×104 1.1×10-2 291 
BCL2[a] 4.4×104 2.4×10-3 53 
[a] Determined by fitting with a modified heterogeneous ligand-binding model 
(two-site binding model). 
Figure S1. SPR-binding assays to evaluate the binding properties of cIKP (1). (a,b) SPR 






























































Figure S2. CD spectra of c-Myc (a), c-kit 1 (b), c-kit 2 (c), and BCL2 (d) ssDNA (5 µM) 
after the addition of 1 (5 to 15 µM) under 50 mM K+ solution. A moderate positive peak at 
262 nm and a negative peak at 240 nm is characteristic of parallel conformations (a,b,c), 
and A positive peak around at 264 and 290 nm and a negative peak around at 240 nm is 



































































































Figure S3. CD spectra of c-Myc (a), c-kit 1 (b), c-kit 2 (c), and BCL2 (d) ssDNA (5 

































































































Figure S4. No induction of G4 formation by TMPyP4 (Figure 1b) by native gel 
electrophoresis under PEG solution; (a) c-Myc dsDNA, (b) c-kit 1 dsDNA, (c) c-kit 2 
dsDNA, (d) BCL2 dsDNA. Lane 1 is a positive control (Posi. Ctrl) for G4 formation 
bands. Lane 2 shows dsDNA bands as negative controls. 
Figure S5. No induction of G4 formation by 1 under no PEG solution by native gel 
electrophoresis; (a) c-Myc dsDNA, (b) c-kit 1 dsDNA, (c) c-kit 2 dsDNA, (d) BCL2 
dsDNA. Lane 1 is a positive control (Posi. Ctrl) for G4 formation bands. Lane 2 shows 
dsDNA bands as negative controls. Concentrations of 1 are 1, 4, and 16 µM for lane 4, 5, 










Figure S6. Induction of G4 formation on c-Myc dsDNA by cIKP (1) in the absence of K+ 
under PEG solution by native gel electrophoresis. Lane 1 is a positive control (Posi. Ctrl) for 
G4 formation bands. Lane 3 shows dsDNA bands as negative controls. Concentrations of 1 
are 1, 2, 4, and 8 µM for lane 4, 5, 6, and 7, respectively.  
Figure S7. Induction effect of G4 formation on c-Myc dsDNA at the lower concentration 
ranges of cIKP (1) in the absence of K+ under PEG solution by native gel electrophoresis. Lane 
1 is a positive control (Posi. Ctrl) for G4 formation bands. Lane 3 shows dsDNA bands as 
negative controls. Concentrations of 1 are 62.5, 125, 250, 500, and 1000 nM for lane 4, 5, 6, 
7, and 8, respectively. 
